In addition to pharmacy inspections, the PSI uses mystery shopper test purchase exercises to assess risks to patient safety by checking compliance with legislation and PSI guidance.
In 2015, a second test purchase exercise was undertaken by the PSI to check whether pharmacies are correctly complying with changed market authorisation and PSI guidance for the safe supply of non-prescription domperidone products. The results indicate some improvements compared to 2014, but concern remains as domperidone was inappropriately supplied in 46% of cases.
A full breakdown of findings along with advice for pharmacists is published on the PSI website.